Vitamin E inhibits endotoxin-mediated transport of phosphatases to lipid rafts

Shock

Volumn 27, Issue 1, 2007, Pages 19-24

  Cuschieri, Joseph ^a,b   Bulger, Eileen ^a   Biligren, Jens ^a   Garcia, Iris ^a   Maier, Ronald V ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

AKT; Macrophage; Oxidants; SHIP; TLR4

Indexed keywords

11,6 HYDROXYMETHYL CHIRO INOSITOL 2,2 O METHYL 3 O OCTADECYLCARBONATE; 2 MORPHOLINO 8 PHENYLCHROMONE; ALPHA TOCOPHEROL SUCCINATE; ENDOTOXIN; HEAT SHOCK PROTEIN 70; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; PROTEIN KINASE B INHIBITOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL SELECTION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID METABOLISM; LIPID RAFT; PROTEIN ANALYSIS;

CELL DIFFERENTIATION; CELL LINE; ENDOTOXINS; HUMANS; LIPOPOLYSACCHARIDES; MACROPHAGES; MEMBRANE MICRODOMAINS; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN TRANSPORT; TOLL-LIKE RECEPTOR 4; VITAMIN E;

EID: 33845695297     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.shk.0000238060.61955.f8     Document Type: Article

References (25)

1. Bishop RE: Fundamentals of endotoxin structure and function. Contrib Microbiol 12:1-27, 2005.
2. Zareie M, Singh PK, Irvine EJ, Sherman PM, McKay DM, Perdue MH: Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease. Am J Pathol 158:1101-1109, 2001.
3. Mueller M, Brandenburg K, Dedrick R, Schromm AB, Seydel U: Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: a role for LPS-binding protein. J Immunol 174:1091-1096, 2005.
4. Fenton MJ, Golenbock DT: LPS-binding proteins and receptors. J Leukoc Biol 64:25-32, 1998.
5. Triantafilou M, Miyake K, Golenbock DT, Triantafilou K: Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 115:2603-2611, 2002.
6. Liu S, Gallo DJ, Green AM, Williams DL, Gong X, Shapiro RA, Gambotto AA, Humphris EL, Vodovotz Y, Billiar TR: Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect Immun 70:3433-3442, 2002.
7. Bulger EM, Garcia I, Maier RV: Dithiocarbamates enhance tumor necrosis factor-alpha production by rabbit alveolar macrophages, despite inhibition of NF-kappaB. Shock 9:397-405, 1998.
8. Bulger EM, Garcia I, Maier RV: Intracellular antioxidant activity is necessary to modulate the macrophage response to endotoxin. Shock 18:58-63, 2002.
9. Bulger EM, Maier RV: An argument for vitamin E supplementation in the management of systemic inflammatory response syndrome. Shock 19:99-103, 2003.
10. Fang H, Pengal RA, Cao X, Ganesan LP, Wewers MD, Marsh CB, Tridandapani S: Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP. J Immunol 173:360-366, 2004.
11. Martin M, Schifferle RE, Cuesta N, Vogel SN, Katz J, Michalek SM: Role of the phosphatidylinositol 3 kinase-Akt pathway in the regulation of IL-10 and IL-12 by Porphyromonas gingivalis lipopolysaccharide. J Immunol 171:717-725, 2003.
12. Sly LM, Rauh MJ, Kalesnikoff J, Song CH, Krystal G: LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 21:227-239, 2004.
13. Beutler B: SHIP, TGF-beta, and endotoxin tolerance. Immunity 21:134-135, 2004.
14. Sly LM, Rauh MJ, Kalesnikoff J, Buchse T, Krystal G: SHIP, SHIP2, and PTEN activities are regulated in vivo by modulation of their protein levels: SHIP is up-regulated in macrophages and mast cells by lipopolysaccharide. Exp Hematol 31:1170-1181, 2003.
15. Anderson RN, Smith BL: Deaths: leading causes for 2002. Natl Vital Stat Rep 53:1-89, 2005.
16. Ware LB: Prognostic determinants of acute respiratory distress syndrome in adults: impact on clinical trial design. Crit Care Med 33:S217-S222, 2005.
17. Traber MG, Packer L: Vitamin E: beyond antioxidant function. Am J Clin Nutr 62:1501S-1509S, 1995.
18. Freedman JE, Farhat JH, Loscalzo J, Keaney JF Jr: Alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 94:2434-2440, 1996.
19. Ricciarelli R, Tasinato A, Clement S, Ozer NK, Boscoboinik D, Azzi A: Alpha-tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem J 334:243-249, 1998.
20. Cuschieri J, Umanskiy K, Solomkin J: PKC-zeta is essential for endotoxin-induced macrophage activation. J Surg Res 121:76-83, 2004.
21. Campbell J, Ciesielski CJ, Hunt AE, Horwood NJ, Beech JT, Hayes LA, Denys A, Feldmann M, Brennan FM, Foxwell BM: A novel mechanism for TNF-alpha regulation by p38 MAPK: involvement of NF-kappa B with implications for therapy in rheumatoid arthritis. J Immunol 173:6928-6937, 2004.
22. Alexander M, Daniel T, Chaudry IH, Schwacha MG: MAP kinases differentially regulate the expression of macrophage hyperactivity after thermal injury. J Cell Physiol 201:35-44, 2004.
23. Kim SH, Kim J, Sharma RP: Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression. Pharmacol Res 49:433-439, 2004.
24. Dahle MK, Overland G, Myhre AE, Stuestol JF, Hartung T, Krohn CD, Mathiesen O, Wang JE, Aasen AO: The phosphatidylinositol 3-kinase/protein kinase B signaling pathway is activated by lipoteichoic acid and plays a role in Kupffer cell production of interleukin-6 (IL-6) and IL-10. Infect Immun 72:5704-5711, 2004.
25. Xie J, Qian J, Yang J, Wang S, Freeman ME 3rd, Yi Q: Critical roles of Raf/MEK/ERK and PI3K/AKT signaling and inactivation of p38 MAP kinase in the differentiation and survival of monocyte-derived immature dendritic cells. Exp Hematol 33:564-572, 2005.